|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the CNXT 10-K filed Nov 26, 2008. Research
and Development
Our research and development (R&D) expenses consist
principally of direct personnel costs to develop new
semiconductor products, allocated indirect costs of the R&D
function, photo mask and other costs for pre-production
evaluation and testing of new devices, and design and test tool
costs. Our R&D expenses also include the costs for design
automation advanced package development and non-cash stock-based
compensation charges for R&D personnel.
R&D expense decreased $48.4 million, or 28%, in fiscal
2008 compared to fiscal 2007. The decrease is due to a 43%
reduction in R&D headcount from September 2007 to September
2008. Other restructuring activities and cost cutting measures
also contributed to the reduction in R&D expense. The
decrease in R&D expense was offset slightly by a correcting
adjustment of $5.3 million, representing the unamortized
portion of the capitalized photo mask costs as of
September 29, 2007. Based upon an evaluation of all
relevant quantitative and qualitative factors, and after
considering the provisions of APB 28, paragraph 29, and
SAB Nos. 99 and 108, we believe that this correcting
adjustment was not material to our estimated full year results
for 2008. In addition, we do not believe the correcting
adjustment is material to the amounts reported in previous
periods.
R&D expense decreased $15.6 million, or 8% in fiscal
2007 compared to fiscal 2006. The decrease is due to a 11%
reduction in R&D headcount from September 2006 to September
2007. Other restructuring activities and cost cutting measures
also contributed to the reduction in R&D expense.
Research and Development Our research and development (R&D) expenses consist principally of direct personnel costs to develop new semiconductor products, allocated indirect costs of the R&D function, photo mask and other costs for pre-production evaluation and testing of new devices, and design and test tool costs. Our R&D expenses also include the costs for design automation advanced package development and non-cash stock-based compensation charges for R&D personnel. R&D expense decreased $48.4 million, or 28%, in fiscal 2008 compared to fiscal 2007. The decrease is due to a 43% reduction in R&D headcount from September 2007 to September 2008. Other restructuring activities and cost cutting measures also contributed to the reduction in R&D expense. The decrease in R&D expense was offset slightly by a correcting adjustment of $5.3 million, representing the unamortized portion of the capitalized photo mask costs as of September 29, 2007. Based upon an evaluation of all relevant quantitative and qualitative factors, and after considering the provisions of APB 28, paragraph 29, and SAB Nos. 99 and 108, we believe that this correcting adjustment was not material to our estimated full year results for 2008. In addition, we do not believe the correcting adjustment is material to the amounts reported in previous periods. R&D expense decreased $15.6 million, or 8% in fiscal 2007 compared to fiscal 2006. The decrease is due to a 11% reduction in R&D headcount from September 2006 to September 2007. Other restructuring activities and cost cutting measures also contributed to the reduction in R&D expense. | EXCERPTS ON THIS PAGE:
RELATED TOPICS for CNXT: |
| |||||||
